Tucatinib addition to trastuzumab and pertuzumab significantly improved PFS in HER2-positive metastatic breast cancer, with a median PFS of 24.9 months versus 16.3 months with placebo. The PFS benefit ...

A University of Alaska Fairbanks assistant research professor pitched a concept Tuesday: Can Delta Junction transform into a ...

After more than 50 years of research, scientists still don't know exactly what causes autism. But the data make clear that ...

SAN ANTONIO -- The antibody-drug conjugate (ADC) sacituzumab govitecan (Trodelvy) failed to outperform chemotherapy as first ...

The fed cattle trade has undergone a tumultuous ride in the past two months. Weekly fed steer prices averaged $237/cwt. the ...

A new University of California San Diego School of Medicine study offers a unified biological model to explain how genetic ...

A compilation of 100 examples of biological tilings shows how repeated natural motifs enhance strength, flexibility and other ...

Patients with relapsed or refractory (R/R) multiple myeloma who received a combination of teclistamab, a bispecific ...

ASH 2025 oral presentation on SENTI-202 in 20 Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) patients (18 response evaluable) shows high efficacy: 50% ORR and 42% CR/CRh (100% of CRs and 83% of ...

A team of scientists from Monash University has identified a single gene in a land plant that could help explain how plants ...

We consulted dermatologists to help unpack what causes hyperpigmentation and share recommendations on the best treatments to add into your routine.

Novavax (NVAX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some ...